Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries – Findings from the EUROASPIRE IV survey
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference38 articles.
1. Dyslipidemias in the prevention of cardiovascular disease: risks and causality;Graham;Curr. Cardiol. Rep.,2012
2. European guidelines on cardiovascular disease prevention in clinical practice (version 2012);Perk;Atherosclerosis,2012
3. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010
4. Statins in the primary prevention of cardiovascular disease;Reiner Ž;Nat. Rev. Cardiol.,2013
5. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American heart association task force on practice guidelines;Stone;Circulation,2014
Cited by 176 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Awareness, dyslipidemia and features of statin therapy in patients with acute coronary syndrome;Meditsinskiy sovet = Medical Council;2024-09-02
2. Prescription patterns of statins in cirrhotic patients: a survey among primary care physicians and cardiologists;Baylor University Medical Center Proceedings;2024-07-08
3. Real-world data on treatment patterns in at least high cardiovascular risk patients on dual and triple lipid lowering therapy in a Hellenic nationwide e-prescription database;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-06
4. Impact of early initiation of ezetimibe in patients with acute coronary syndrome: A systematic review and meta-analysis;European Journal of Internal Medicine;2024-06
5. Rapid achievement of low-density lipoprotein cholesterol goals within 1 month after acute coronary syndrome during combination therapy with rosuvastatin, ezetimibe and bempedoic acid: Initial experience from the LAI-REACT study;Journal of Clinical Lipidology;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3